Ralph Noeske
Ralph Noeske has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Adre du Plessis
The George Washington University School of Medicine, District of Columbia, United States
1 shared publication - Amy E. Bouchard
Department of Radiology, Weill Cornell Medicine, New York, NY, United States
1 shared publication Baolian Yang
GE Healthcare, Waukesha, Wisconsin, USA
1 shared publication- Catherine Limperopoulos
Developing Brain Institute, Children’s National Hospital, Washington, USA
1 shared publication - Chu-Yu Lee
Department of Radiology University of Iowa Iowa City Iowa USA
1 shared publication - Dikoma C. Shungu
Department of Radiology, Weill Cornell Medicine, New York, USA
1 shared publication
Latest Publications
- Open Access
Evaluations of retrospective frequency and phase correction methods for single-voxel MR spectroscopy at 7T
Subject motion and gradient heating-induced frequency and phase offsets result in spectral misalignment during single-voxel MR spectroscopy (SVS) acquisitions. Several methods have been presented to align the spectra, but their performance on a 7T system is unclear. This study aimed to evaluate the practical importance of four retrospective correction methods, namely creatine fitting, residual water, spectral registration, and cross-correlation. SVS data were collected from 127 participants (88/39 female/male, 39±15 years) using a semi-localization by adiabatic selective refocusing sequence at 7T. Changes in the spectral linewidth, signal-to-noise ratio (SNR), similarity (mean similarity matrix (SI mean )), and metabolite quantification (concentration, relative Cramer-Rao lower bounds (rCRLB)) after correction were evaluated. A Wilcoxon signed rank test was used to evaluate these changes. The p -values were adjusted using the false discovery rate ( q 0.60). The correction only showed a weak to moderate effect of the changes in the metabolite quantification (effect size<0.60), suggesting that whether the correction results in more reliable metabolite quantification requires further validation.
Open AccessEvaluations of retrospective frequency and phase correction methods for single-voxel MR spectroscopy at 7T
Subject motion and gradient heating-induced frequency and phase offsets result in spectral misalignment during single-voxel MR spectroscopy (SVS) acquisitions. Several methods have been presented to align the spectra, but their performance on a 7T system is unclear. This study aimed to evaluate the practical importance of four retrospective correction methods, namely creatine fitting, residual water, spectral registration, and cross-correlation. SVS data were collected from 127 participants (88/39 female/male, 39±15 years) using a semi-localization by adiabatic selective refocusing sequence at 7T. Changes in the spectral linewidth, signal-to-noise ratio (SNR), similarity (mean similarity matrix (SI mean )), and metabolite quantification (concentration, relative Cramer-Rao lower bounds (rCRLB)) after correction were evaluated. A Wilcoxon signed rank test was used to evaluate these changes. The p -values were adjusted using the false discovery rate ( q 0.60). The correction only showed a weak to moderate effect of the changes in the metabolite quantification (effect size<0.60), suggesting that whether the correction results in more reliable metabolite quantification requires further validation.
- Open Access
Test-retest reliability of multi-metabolite edited MRS at 3T using PRESS and sLASER
Purpose: Spectral editing is the most common MRS approach for noninvasive in vivo measurement of low-concentration, strongly overlapped metabolites in the brain, such as γ-aminobutyric acid (GABA) and glutathione (GSH). Multi-metabolite editing methods, including HERMES and HERCULES, have recently been introduced, where multiple J -coupled metabolites can be edited in a single acquisition without increasing total scan time. Yet little is known regarding the reliability of these methods. This study assessed the test-retest reliability of HERMES and HERCULES, where volume localization was achieved using either PRESS or sLASER. Methods: Sixteen healthy adult volunteers were scanned twice in two separate sessions. Single-voxel edited MRS data were acquired in the medial parietal lobe using the following sequences: (1) HERMES-PRESS; (2) HERMES-sLASER; (3) HERCULES-PRESS; (4) HERCULES-sLASER. Spectra were processed and metabolites were quantified using the Osprey software. Data quality metrics and reliability statistics were estimated for all four acquisitions. Results: HERMES-sLASER demonstrated lower within-subjects coefficients of variation (CV ws ) for GSH, glutamine (Gln), and glutamate (Glu) + Gln (Glx), suggesting improved reliability compared to HERMES-PRESS. However, GABA + co-edited macromolecules (GABA+) and Glu showed higher CV ws for HERMES-sLASER. HERCULES-sLASER produced better reliability than HERCULES-PRESS for GABA+, GSH, Glu, Gln, Glx, aspartate (Asp), and lactate (Lac). N -acetylaspartate (NAA) and N -acetylaspartylglutamate (NAAG) showed higher CV ws for HERCULES-sLASER. These findings suggest that sLASER may be more advantageous than PRESS for volume localization in simultaneous multi-metabolite editing. Conclusion: Using sLASER yielded better test-retest reliability for most metabolites than using PRESS for volume localization for HERMES and HERCULES.
Open AccessTest-retest reliability of multi-metabolite edited MRS at 3T using PRESS and sLASER
Purpose: Spectral editing is the most common MRS approach for noninvasive in vivo measurement of low-concentration, strongly overlapped metabolites in the brain, such as γ-aminobutyric acid (GABA) and glutathione (GSH). Multi-metabolite editing methods, including HERMES and HERCULES, have recently been introduced, where multiple J -coupled metabolites can be edited in a single acquisition without increasing total scan time. Yet little is known regarding the reliability of these methods. This study assessed the test-retest reliability of HERMES and HERCULES, where volume localization was achieved using either PRESS or sLASER. Methods: Sixteen healthy adult volunteers were scanned twice in two separate sessions. Single-voxel edited MRS data were acquired in the medial parietal lobe using the following sequences: (1) HERMES-PRESS; (2) HERMES-sLASER; (3) HERCULES-PRESS; (4) HERCULES-sLASER. Spectra were processed and metabolites were quantified using the Osprey software. Data quality metrics and reliability statistics were estimated for all four acquisitions. Results: HERMES-sLASER demonstrated lower within-subjects coefficients of variation (CV ws ) for GSH, glutamine (Gln), and glutamate (Glu) + Gln (Glx), suggesting improved reliability compared to HERMES-PRESS. However, GABA + co-edited macromolecules (GABA+) and Glu showed higher CV ws for HERMES-sLASER. HERCULES-sLASER produced better reliability than HERCULES-PRESS for GABA+, GSH, Glu, Gln, Glx, aspartate (Asp), and lactate (Lac). N -acetylaspartate (NAA) and N -acetylaspartylglutamate (NAAG) showed higher CV ws for HERCULES-sLASER. These findings suggest that sLASER may be more advantageous than PRESS for volume localization in simultaneous multi-metabolite editing. Conclusion: Using sLASER yielded better test-retest reliability for most metabolites than using PRESS for volume localization for HERMES and HERCULES.
- Open Access
- 14 December 2017
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 39 (2) , 375-379
Measuring Cerebral and Cerebellar Glutathione in Children Using1H MEGA-PRESS MRS
BACKGROUND AND PURPOSE: Glutathione is an important antioxidant in the human brain and therefore of interest in neurodegenerative disorders. The purpose of this study was to investigate the feasibility of measuring glutathione in healthy nonsedated children by using the 1H Mescher-Garwood point-resolved spectroscopy (MEGA-PRESS) sequence at 3T and to compare glutathione levels between the medial parietal gray matter and the cerebellum. MATERIALS AND METHODS: Glutathione was measured using MEGA-PRESS MRS (TR = 1.8 seconds, TE = 131 ms) in the parietal gray matter (35 × 25 × 20 mm3) of 6 healthy children (10.0 ± 2.4 years of age; range, 7–14 years; 3 males) and in the cerebellum of 11 healthy children (12.0 ± 2.7 years of age; range, 7–16 years; 6 males). A postprocessing pipeline was developed to account for frequency and phase variations in the edited ON and nonedited OFF spectra. Metabolites were quantified with LCModel and reported both as ratios and water-scaled values. Glutathione was quantified in the ON-OFF spectra, whereas total NAA, total Cho, total Cr, mIns, Glx, and taurine were quantified in the OFF spectra. RESULTS: We found significantly higher glutathione, total Cho, total Cr, mIns, and taurine in the cerebellum (P < .01). Glx and total NAA were significantly higher in the parietal gray matter (P < .01). There was no significant difference in glutathione/total Cr (P = .93) between parietal gray matter and cerebellum. CONCLUSIONS: We demonstrated that glutathione measurement in nonsedated children is feasible. We found significantly higher glutathione in the cerebellum compared with the parietal gray matter. Metabolite differences between the parietal gray matter and cerebellum agree with published MRS data in adults.
- 14 December 2017
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 39 (2) , 375-379
Open AccessMeasuring Cerebral and Cerebellar Glutathione in Children Using1H MEGA-PRESS MRS
BACKGROUND AND PURPOSE: Glutathione is an important antioxidant in the human brain and therefore of interest in neurodegenerative disorders. The purpose of this study was to investigate the feasibility of measuring glutathione in healthy nonsedated children by using the 1H Mescher-Garwood point-resolved spectroscopy (MEGA-PRESS) sequence at 3T and to compare glutathione levels between the medial parietal gray matter and the cerebellum. MATERIALS AND METHODS: Glutathione was measured using MEGA-PRESS MRS (TR = 1.8 seconds, TE = 131 ms) in the parietal gray matter (35 × 25 × 20 mm3) of 6 healthy children (10.0 ± 2.4 years of age; range, 7–14 years; 3 males) and in the cerebellum of 11 healthy children (12.0 ± 2.7 years of age; range, 7–16 years; 6 males). A postprocessing pipeline was developed to account for frequency and phase variations in the edited ON and nonedited OFF spectra. Metabolites were quantified with LCModel and reported both as ratios and water-scaled values. Glutathione was quantified in the ON-OFF spectra, whereas total NAA, total Cho, total Cr, mIns, Glx, and taurine were quantified in the OFF spectra. RESULTS: We found significantly higher glutathione, total Cho, total Cr, mIns, and taurine in the cerebellum (P < .01). Glx and total NAA were significantly higher in the parietal gray matter (P < .01). There was no significant difference in glutathione/total Cr (P = .93) between parietal gray matter and cerebellum. CONCLUSIONS: We demonstrated that glutathione measurement in nonsedated children is feasible. We found significantly higher glutathione in the cerebellum compared with the parietal gray matter. Metabolite differences between the parietal gray matter and cerebellum agree with published MRS data in adults.
- Open Access
- 24 September 2015
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 37 (2) , 360-366
Elucidating Metabolic Maturation in the Healthy Fetal Brain Using1H-MR Spectroscopy
BACKGROUND AND PURPOSE: 1H-MRS provides a noninvasive way to study fetal brain maturation at the biochemical level. The purpose of this study was to characterize in vivo metabolic maturation in the healthy fetal brain during the second and third trimester using 1H-MRS. MATERIALS AND METHODS: Healthy pregnant volunteers between 18 and 40 weeks gestational age underwent single voxel 1H-MRS. MR spectra were retrospectively corrected for motion-induced artifacts and quantified using LCModel. Linear regression was used to examine the relationship between absolute metabolite concentrations and ratios of total NAA, Cr, and Cho to total Cho and total Cr and gestational age. RESULTS: Two hundred four spectra were acquired from 129 pregnant women at mean gestational age of 30.63 ± 6 weeks. Total Cho remained relatively stable across the gestational age (r2 = 0.04, P = .01). Both total Cr (r2 = 0.60, P < .0001) as well as total NAA and total NAA to total Cho (r2 = 0.58, P < .0001) increased significantly between 18 and 40 weeks, whereas total NAA to total Cr exhibited a slower increase (r2 = 0.12, P < .0001). Total Cr to total Cho also increased (r2 = 0.53, P < .0001), whereas total Cho to total Cr decreased (r2 = 0.52, P < .0001) with gestational age. The cohort was also stratified into those that underwent MRS in the second and third trimesters and analyzed separately. CONCLUSIONS: We characterized metabolic changes in the normal fetal brain during the second and third trimesters of pregnancy and derived normative metabolic indices. These reference values can be used to study metabolic maturation of the fetal brain in vivo.
- 24 September 2015
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 37 (2) , 360-366
Open AccessElucidating Metabolic Maturation in the Healthy Fetal Brain Using1H-MR Spectroscopy
BACKGROUND AND PURPOSE: 1H-MRS provides a noninvasive way to study fetal brain maturation at the biochemical level. The purpose of this study was to characterize in vivo metabolic maturation in the healthy fetal brain during the second and third trimester using 1H-MRS. MATERIALS AND METHODS: Healthy pregnant volunteers between 18 and 40 weeks gestational age underwent single voxel 1H-MRS. MR spectra were retrospectively corrected for motion-induced artifacts and quantified using LCModel. Linear regression was used to examine the relationship between absolute metabolite concentrations and ratios of total NAA, Cr, and Cho to total Cho and total Cr and gestational age. RESULTS: Two hundred four spectra were acquired from 129 pregnant women at mean gestational age of 30.63 ± 6 weeks. Total Cho remained relatively stable across the gestational age (r2 = 0.04, P = .01). Both total Cr (r2 = 0.60, P < .0001) as well as total NAA and total NAA to total Cho (r2 = 0.58, P < .0001) increased significantly between 18 and 40 weeks, whereas total NAA to total Cr exhibited a slower increase (r2 = 0.12, P < .0001). Total Cr to total Cho also increased (r2 = 0.53, P < .0001), whereas total Cho to total Cr decreased (r2 = 0.52, P < .0001) with gestational age. The cohort was also stratified into those that underwent MRS in the second and third trimesters and analyzed separately. CONCLUSIONS: We characterized metabolic changes in the normal fetal brain during the second and third trimesters of pregnancy and derived normative metabolic indices. These reference values can be used to study metabolic maturation of the fetal brain in vivo.